Provided by Tiger Trade Technology Pte. Ltd.

Minerva Neurosciences

6.34
-0.1100-1.71%
Pre-market: 6.32-0.0200-0.32%07:58 EST
Volume:163.47K
Turnover:1.03M
Market Cap:274.36M
PE:-3.42
High:6.58
Open:6.29
Low:5.66
Close:6.45
52wk High:12.46
52wk Low:1.15
Shares:43.27M
Float Shares:5.44M
Volume Ratio:1.75
T/O Rate:3.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8533
EPS(LYR):0.1901
ROE:-675.09%
ROA:-25.82%
PB:-7.93
PE(LYR):33.35

Loading ...

Minerva Neurosciences Inc expected to post a loss of 30 cents a share - Earnings Preview

Reuters
·
13 mins ago

Analysts Have Conflicting Sentiments on These Healthcare Companies: Minerva Neurosciences (NERV) and Verastem (VSTM)

TIPRANKS
·
Feb 04

Minerva Neurosciences veröffentlicht Präsentation zu neuem Therapieansatz für Negativsymptome bei Schizophrenie

Reuters
·
Feb 04

Minerva Neurosciences kündigt virtuelle Expertenveranstaltung zu Phase-3-Studie mit Roluperidon an

Reuters
·
Feb 03

Minerva Neurosciences Hosts Virtual KOL Event on Roluperidone for Negative Symptoms of Schizophrenia

Reuters
·
Jan 26

Minerva Neurosciences Inc. Held Annual Shareholder Meeting

Reuters
·
Dec 23, 2025

Minerva Neurosciences Expands Board Amid Fundraising Effort

TIPRANKS
·
Nov 19, 2025

BRIEF-Minerva Neurosciences Appoints Dr. Inderjit Kaul To The Company’S Board Of Directors

Reuters
·
Nov 19, 2025

Minerva Neurosciences Appoints Dr. Inderjit Kaul to Board of Directors

Reuters
·
Nov 19, 2025

Minerva Neurosciences Appoints DR. Inderjit Kaul to the Company’s Board of Directors

THOMSON REUTERS
·
Nov 19, 2025

Minerva Neurosciences Files Initial Beneficial Ownership Statement for Director Inderjit Kaul

Reuters
·
Nov 19, 2025

Minerva Neurosciences Inc. Announces Date for Upcoming Annual Stockholders Meeting

Reuters
·
Nov 15, 2025

Minerva Neurosciences Reports Q3 2025 Financial Results

TIPRANKS
·
Nov 11, 2025

Minerva Neurosciences (NERV) Gets a Hold from H.C. Wainwright

TIPRANKS
·
Nov 10, 2025

Minerva Neurosciences Is Maintained at Neutral by HC Wainwright & Co.

Dow Jones
·
Nov 06, 2025

Minerva price target lowered to $4 from $5 at H.C. Wainwright

TIPRANKS
·
Nov 06, 2025

Minerva Neurosciences reports $2.7 mln Q3 net loss

Reuters
·
Nov 05, 2025

Minerva Neurosciences Q3 EPS $(0.36) Misses $(0.35) Estimate

Benzinga
·
Nov 05, 2025

BRIEF-Minerva Neurosciences Q3 Net Income USD -2.744 Million

Reuters
·
Nov 05, 2025

Minerva Neurosciences Secures $80 Million Financing and Plans Phase 3 Roluperidone Trial

Reuters
·
Nov 05, 2025